Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Cancers
|
September 10, 2021
T-cell Redirecting Therapies for the Treatment of B-cell Lymphomas: Recent Advances
Ondine Messéant, Roch Houot, Guillaume Manson
Methods in Molecular Biology (Clifton, N.J.)
|
November 25, 2020
High-Dimensional Phenotyping of Human Myeloid-Derived Suppressor Cells/Tumor-Associated Macrophages in Tissue by Mass Cytometry
Juliette Ferrant, Simon Le Gallou, Guillaume Manson, et al.
Blood Advances
|
March 19, 2024
Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicity
Matteo Mauget, Sophie Lemercier, Quentin Quelven, et al.
European Radiology
|
March 28, 2022
Interpretation of 2-[<sup>18</sup>F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors
Guillaume Manson, Amaeshi Chukwunonye Lemchukwu, Fatima-Zohra Mokrane, et al.
Clinical Nuclear Medicine
|
November 28, 2023
Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma
Mehdi Mouheb, Morgane Pierre-Jean, Anne Devillers, et al.
Hemasphere
|
May 28, 2024
Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?
Alya Perthus, Fanny Colin, Emilie Charton, et al.
Blood
|
March 9, 2017
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Charles Herbaux, Jordan Gauthier, Pauline Brice, et al.
Radiology
|
December 6, 2022
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
Laurent Dercle, Shawn Sun, Romain-David Seban, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 23, 2021
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study
Marion Panhaleux, Olivier Espitia, Benjamin Terrier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
Guillaume Manson, Jean-Baptiste Mear, Charles Herbaux, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Cancers
|
September 10, 2021
T-cell Redirecting Therapies for the Treatment of B-cell Lymphomas: Recent Advances
Ondine Messéant, Roch Houot, Guillaume Manson
Methods in Molecular Biology (Clifton, N.J.)
|
November 25, 2020
High-Dimensional Phenotyping of Human Myeloid-Derived Suppressor Cells/Tumor-Associated Macrophages in Tissue by Mass Cytometry
Juliette Ferrant, Simon Le Gallou, Guillaume Manson, et al.
Blood Advances
|
March 19, 2024
Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicity
Matteo Mauget, Sophie Lemercier, Quentin Quelven, et al.
European Radiology
|
March 28, 2022
Interpretation of 2-[<sup>18</sup>F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors
Guillaume Manson, Amaeshi Chukwunonye Lemchukwu, Fatima-Zohra Mokrane, et al.
Clinical Nuclear Medicine
|
November 28, 2023
Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma
Mehdi Mouheb, Morgane Pierre-Jean, Anne Devillers, et al.
Hemasphere
|
May 28, 2024
Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?
Alya Perthus, Fanny Colin, Emilie Charton, et al.
Blood
|
March 9, 2017
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Charles Herbaux, Jordan Gauthier, Pauline Brice, et al.
Radiology
|
December 6, 2022
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
Laurent Dercle, Shawn Sun, Romain-David Seban, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 23, 2021
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study
Marion Panhaleux, Olivier Espitia, Benjamin Terrier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
Guillaume Manson, Jean-Baptiste Mear, Charles Herbaux, et al.
Page
of 3